Abstract:Stroke, Ahead of Print. Background:CYP2B6 (cytochrome P450 subfamily IIB polypeptide 6), encoded by theCYP2B6gene, is a critical enzyme involved in clopidogrel metabolism. However, the association betweenCYP2B6polymorphisms and the efficacy of clopidogrel in minor stroke or transient ischemic attack for secondary stroke prevention remains unclear.Methods:Based on CHANCE (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events) randomized clinical trial of aspirin plus clopidogrel versus aspirin alone, we investigated the role ofCYP2B6polymorphisms and the efficacy of clopidogrel in patients with minor stroke or transient ischemic attack in China from October 2009 to July 2012. A total of 2853 patients were successfully genotyped forCYP2B6-516G>T, rs3745274 andCYP2B6-1456 T>C, rs2054675. The primary efficacy and safety outcomes were new stroke and any bleeding within 90 days.Results:Among the 2853 patients, 32.8% were identified as the carriers of theCYP2B6-516 GT/TT or -1456 TC/CC genotype. The incidences of 90-day new stroke in aspirin plus clopidogrel and aspirin alone groups were 7.1% versus 11.3% among noncarriers, respectively; and 9.7% versus 12.2% among carriers, respectively. The efficacy of aspirin plus clopidogrel versus aspirin alone was not significantly different (Pinteraction=0.29) in noncarriers (adjusted hazard ratio, 0.61 [95% CI, 0.45–0.83]) compared to carriers (adjusted hazard ratio, 0.80 [95% CI, 0.54–1.18]). The incidence (n=51) of 90-day any bleeding in aspirin plus clopidogrel and aspirin alone groups were 2.2% (21 bleeds) versus 1.9% (18 bleeds) among noncarriers (adjusted hazard ratio, 1.11 [95% CI, 0.59–2.09]) and 1.9% (9 bleeds) versus 0.7% (3 bleeds) among carriers (adjusted hazard ratio, 3.23 [95% CI, 0.86–12.12]). Similar findings were observed during the 1-year follow-up.Conclusions:In this post hoc analysis of the CHANCE trial, we did not observe a significant difference in the efficacy of aspirin plus clopidogrel compared with aspirin in carriers versus noncarriers ofCYP2B6-516 GT/TT or -1456 TC/CC genotype. Our results suggest that both carriers and noncarriers suffering from a minor stroke are likely to benefit from aspirin plus clopidogrel treatment over aspirin monotherapy for secondary prevention.REGISTRATION:URL:https://www.clinicaltrials.gov; Unique identifier: NCT00979589.

CYP Metabolic Pathway Related Gene Polymorphism Increases the Risk of Embolic and Atherothrombotic Stroke and Vulnerable Carotid Plaque in Southeast China.

A Study of the Relationship Between Carotid Artery Arteriosclerosis in Patients with Cerebral Stroke and Angiotensin Converting Enzyme Gene Polymorphism and Blood Lipids

EDNRA Gene rs1878406 Polymorphism is Associated With Susceptibility to Large Artery Atherosclerotic Stroke

Association between phosphodiesterase 4D gene polymorphism and carotid atherosclerosis in patients with cerebral infarction

Genetic Polymorphisms and Related Risk Factors of Ischemic Stroke in a Mongolian Population in China

Genetic Variations of CYP19A1 Gene and Stroke Susceptibility: A Case-Control Study in the Chinese Han Population.

CYP4 subfamily V member 2 ( CYP4V2 ) polymorphisms were associated with ischemic stroke in Chinese Han population

The effects of CES 1 A 2 and CYP 2 C 19 polymorphisms on responsiveness to clopidogrel and clinical outcomes among Chinese patients with acute ischemic stroke

CYP2C19 Polymorphisms and Antiplatelet Effects of Clopidogrel in Acute Ischemic Stroke in China

Polymorphisms in CYP450 Genes and the Therapeutic Effect of Atorvastatin on Ischemic Stroke: A Retrospective Cohort Study in Chinese Population

Association Studies of Genetic Polymorphism, Environmental Factors and Their Interaction in Ischemic Stroke

Association of Antihypertensive Drug-Related Gene Polymorphisms with Stroke in the Chinese Hypertensive Population

Inflammation and endothelial function‐related gene polymorphisms are associated with carotid atherosclerosis—A study of community population in Southwest China

Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia.

Genetic variants in CYP4F2 were significantly correlated with susceptibility to ischemic stroke.

Association of CYP2J2 gene polymorphisms with ischemic stroke

Inflammation and endothelial function relevant genetic polymorphisms in carotid stenosis in southwestern China

The association of lipid metabolism relative gene polymorphisms and ischemic stroke in Han and Uighur population of Xinjiang

Association of C7673t Polymorphism in Apolipoprotein B Gene with Ischemic Stroke in the Chinese Population: A Meta-Analysis

Association Between CYP2B6 Polymorphisms and Efficacy of Clopidogrel in Minor Stroke or Transient Ischemic Attack

Association of ACYP2 and TSPYL6 Genetic Polymorphisms with Risk of Ischemic Stroke in Han Chinese Population